Male Infertility Treatment Market Analysis
Male infertility refers to the inability of male to cause pregnancy in a fertile woman. A variety of the problems ranging from hormonal disturbances to physical, psychological problems can cause male infertility. Hormonal problems include hyperprolactinemia, hypothyroidism, panhypopituitarism and others. Physical problems include varicocele, torsion, damaged sperm ducts and others. Furthermore, Erectile dysfunction, premature ejaculation and ejaculatory incompetence may lead to male infertility. Although many treatments are available for male infertility, in many cases treatment will not work. In many of the cases, male infertility is caused by testicular damage that leads to the inability of sperm production. In addition, low sperm production and poor sperm quality are also major causes of male infertility.
Male Infertility Treatment Market Drivers and Restrains
The market is mainly driven by the steady increase in infertility rates globally. In addition, change in lifestyles and growing ageing population are also influencing the growth of the male infertility drugs market over the forecast period. Furthermore, recent advancements in infertility treatment and growing awareness related to the available treatment options and drugs are expected to bolster the market growth during the forecast period. However, unavailability of effective therapies or drugs for the treatment and social inhibitions are expected to hamper the male infertility drugs market during the forecast period.
The market is driven by the steady growth rate in infertility, rising burden of conditions such as obesity and smoking around the world who are more susceptible to become infertile. Companies are focusing on the development of new treatment methods to cope with the increase in demand for the male infertility treatment. For Instance, in May 2017, OncBioMune Pharmaceuticals, Inc. received approval for its male fertility product Andfrt in Mexico by Mexican Ministry of Health. Furthermore many of the drugs such as letrozole, clomid and tamoxifen are used as off-label drugs for the treatment of male infertility.
Male Infertility Treatment Market is segmented based on product type, distribution channel
Based on product type, it is segmented into
- Gonadotropin hormone
- Recombinant Follicle Stimulation Hormone
Based on distribution channel, it is segmented into
- Hospital Pharmacies
- Retail Pharmacies
Region Analysis: Global Male Infertility Treatment Market
Geographically, the market has been segmented into Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America market is expected to grow at significant rates owing to the factors such as well-established healthcare infrastructure, favourable government policies and growing awareness regarding the various treatment options available. Europe is expected to grow at significant rates owing to developed healthcare infrastructure, growing awareness. Asia Pacific and African region is expected to grow at faster rates owing to a high number of cases in the region and developing healthcare infrastructure and expansion of multinational companies into developing countries such as India and China.
Some of the players in male infertility market are OncBioMune Pharmaceutical (U.S.), The Merck Group (EMD Serono Inc.) (Germany), Endo International plc (U.S.), Sanofi (France), SalNature, LLC (U.S.), Active Bio Life Science GmbH (Germany), Bayer AG (Germany) and Intas Pharmaceuticals Limited to name a few
Notable Market Developments:
- In June 2017, Sal Nature LLC, new market player launched FertileHerb, the first such herbal supplement made in the United States
Key Features of the Report
- The report provides granular level information about The market size, regional market share, and forecast from 2018-2024
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup’s details that are working in the industry
- The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario